SCHEMBL7224762

SCHEMBL7224762

NC(=O)C=Cc1ccc(S(=O)(=O)Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.44
CA2 P00918 3/20 0.43
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA9 Q16790 2/20 0.43
PELI1 Q96FA3 1/20 0.43
CYP1A2 P05177 1/20 0.41
HDAC1 Q13547 3/20 0.40
HDAC8 Q9BY41 2/20 0.40
NPC1 O15118 2/20 0.40
GAA P10253 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6848105 0.83 CA2 (0.57) CA2CA12CA1CA9PELI1
SCHEMBL1373939 0.83 HCAR2 (0.57) MAOBCA2CA12CA1CA9
SCHEMBL27827422 0.83 TDP1 (0.52) MAOBCA2CA12CA1CA9
SCHEMBL1375276 0.83 HCAR2 (0.57) MAOBCA2CA12CA1CA9
SCHEMBL1450230 0.82 F3 (0.52) MAOBCA2CA12CA1CA9
SCHEMBL2225869 0.81 MAOB (0.59) MAOBCA2PELI1CYP1A2ALDH1A1
SCHEMBL6557373 0.80 TDP1 (0.52) MAOBNPC1ALDH1A1HSD17B10TDP1
SCHEMBL6557376 0.80 TDP1 (0.52) MAOBNPC1ALDH1A1HSD17B10TDP1
SCHEMBL7222824 0.77 MAOB (0.44) MAOBHDAC1HDAC8NPC1GAA
SCHEMBL28207122 0.77 CA2 (0.62) MAOBCA2CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6559167-B1 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-05-06 US disclosed